Jens Kastrup

About

Professor Jens Kastrup, MD DMSc, is a faculty member at Rigshospitalet University of Copenhagen, Denmark. His research primarily focuses on the effectiveness and safety of mesenchymal stromal cell therapy, particularly for conditions stemming from radiation-induced hyposalivation in head and neck cancer survivors. He is also involved in the clinical development of new therapies for refractory angina and has explored the implications of coronary flow velocity reserve in women with angina. His work contributes significantly to the fields of regenerative medicine and vascular biology.